Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia
Condition:   Primary Immunodeficiency Diseases Intervention:   Device: IgG deficiency rapid screening test Sponsors:   PATH;   Bill and Melinda Gates Foundation;   Institut Pasteur de Tunis;   Centre National de Greffe de Moelle Osseuse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials